Swiss National Bank’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-184,978
Closed -$2.84M 2319
2025
Q4
$2.84M Sell
184,978
-2,000
-1% -$22K ﹤0.01% 1691
2025
Q3
$1.86M Hold
186,978
﹤0.01% 1891
2025
Q2
$1.85M Sell
186,978
-42,200
-18% -$445K ﹤0.01% 1842
2025
Q1
$2.97M Sell
229,178
-2,800
-1% -$37.1K ﹤0.01% 1547
2024
Q4
$2.96M Sell
231,978
-12,100
-5% -$146K ﹤0.01% 1627
2024
Q3
$2.72M Hold
244,078
﹤0.01% 1681
2024
Q2
$2.74M Buy
244,078
+1,500
+0.6% +$17.5K ﹤0.01% 1644
2024
Q1
$3.01M Sell
242,578
-11,300
-4% -$147K ﹤0.01% 1611
2023
Q4
$3.55M Sell
253,878
-28,500
-10% -$396K ﹤0.01% 1495
2023
Q3
$4.17M Buy
282,378
+2,700
+1% +$38K ﹤0.01% 1385
2023
Q2
$3.61M Buy
279,678
+18,100
+7% +$206K ﹤0.01% 1503
2023
Q1
$2.57M Sell
261,578
-28,500
-10% -$304K ﹤0.01% 1673
2022
Q4
$3.09M Buy
290,078
+5,500
+2% +$63.9K ﹤0.01% 1621
2022
Q3
$2.97M Buy
284,578
+16,200
+6% +$211K ﹤0.01% 1600
2022
Q2
$3.38M Sell
268,378
-15,200
-5% -$161K ﹤0.01% 1566
2022
Q1
$3.07M Buy
283,578
+30,400
+12% +$369K ﹤0.01% 1766
2021
Q4
$3.56M Hold
253,178
﹤0.01% 1683
2021
Q3
$4.86M Buy
253,178
+3,500
+1% +$46.5K ﹤0.01% 1482
2021
Q2
$2.46M Buy
249,678
+23,100
+10% +$210K ﹤0.01% 1966
2021
Q1
$2.23M Buy
226,578
+3,700
+2% +$30.5K ﹤0.01% 1933
2020
Q4
$992K Buy
222,878
+6,300
+3% +$28.5K ﹤0.01% 2290
2020
Q3
$936K Buy
216,578
+3,200
+1% +$22.8K ﹤0.01% 2120
2020
Q2
$1.89M Buy
213,378
+53,100
+33% +$268K ﹤0.01% 1746
2020
Q1
$566K Hold
160,278
﹤0.01% 2126
2019
Q4
$917K Buy
160,278
+3,400
+2% +$18.2K ﹤0.01% 2184
2019
Q3
$561K Buy
156,878
+37,800
+32% +$147K ﹤0.01% 2322
2019
Q2
$475K Buy
119,078
+4,800
+4% +$27.8K ﹤0.01% 2427
2019
Q1
$835K Buy
114,278
+3,600
+3% +$35.2K ﹤0.01% 2167
2018
Q4
$1.01M Buy
110,678
+6,500
+6% +$71.9K ﹤0.01% 2002
2018
Q3
$1.29M Hold
104,178
﹤0.01% 1997
2018
Q2
$1.59M Hold
104,178
﹤0.01% 1857
2018
Q1
$2.07M Buy
104,178
+4,300
+4% +$74.3K ﹤0.01% 1615
2017
Q4
$1.87M Hold
99,878
﹤0.01% 1680
2017
Q3
$2.15M Buy
99,878
+28,900
+41% +$457K ﹤0.01% 1577
2017
Q2
$685K Buy
70,978
+14,400
+25% +$93.5K ﹤0.01% 2290
2017
Q1
$337K Hold
56,578
﹤0.01% 2467
2016
Q4
$223K Hold
56,578
﹤0.01% 2544
2016
Q3
$594K Sell
56,578
-2,200
-4% -$31.6K ﹤0.01% 2261
2016
Q2
$857K Sell
58,778
-2,300
-4% -$39.3K ﹤0.01% 2054
2016
Q1
$1.13M Buy
61,078
+12,550
+26% +$254K ﹤0.01% 1827
2015
Q4
$1.17M Buy
48,528
+2,600
+6% +$65.1K ﹤0.01% 1708
2015
Q3
$1.13M Buy
45,928
+18,788
+69% +$532K ﹤0.01% 1704
2015
Q2
$636K Hold
27,140
﹤0.01% 2089
2015
Q1
$609K Hold
27,140
﹤0.01% 2061
2014
Q4
$458K Hold
27,140
﹤0.01% 2228
2014
Q3
$388K Hold
27,140
﹤0.01% 2233
2014
Q2
$434K Hold
27,140
﹤0.01% 2243
2014
Q1
$489K Buy
27,140
+8,120
+43% +$151K ﹤0.01% 2129
2013
Q4
$373K Buy
19,020
+4,900
+35% +$71.7K ﹤0.01% 2167
2013
Q3
$169K Sell
14,120
-1,600
-10% -$20.1K ﹤0.01% 2390
2013
Q2
$173K Buy
+15,720
New +$331K ﹤0.01% 2394

Other funds holding DVAX

Swiss National Bank's DVAX Position: Q1 2026 in Review

Swiss National Bank sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 184,978 shares — an estimated $2.84M sold.

Swiss National Bank first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $4.86M in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Swiss National Bank reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Swiss National Bank sold 184,978 Dynavax Technologies shares in Q1 2026, an estimated $2.84M.
  • Swiss National Bank first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
  • Swiss National Bank's Dynavax Technologies position peaked at $4.86M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.